Free Fatty Acids Increase Intracellular Lipid Accumulation and Oxidative Stress by Modulating PPARα and SREBP-1c in L-02 Cells

Hydrogen peroxide impairs autophagic flux in a cell model of nonalcoholic fatty liver disease

(2013) Pengtao Jiang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα)

(2013) Li-juan Shi et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Amelioration by chicory seed extract of diabetes- and oleic acid-induced non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) via modulation of PPARα and SREBP-1

(2013) Nasrin Ziamajidi et al.   FOOD AND CHEMICAL TOXICOLOGY

Quercetin ameliorate insulin resistance and up-regulates cellular antioxidants during oleic acid induced hepatic steatosis in HepG2 cells

(2013) Satyakumar Vidyashankar et al.   TOXICOLOGY IN VITRO

Herbacetin induces apoptosis in HepG2 cells: Involvements of ROS and PI3K/Akt pathway

(2012) Yan Qiao et al.   FOOD AND CHEMICAL TOXICOLOGY

CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease

(2012) Tung-Ming Leung et al.   JOURNAL OF HEPATOLOGY

Liv.52 up-regulates cellular antioxidants and increase glucose uptake to circumvent oleic acid induced hepatic steatosis in HepG2 cells

(2012) Satyakumar Vidyashankar et al.   PHYTOMEDICINE

Roles of PPARs in NAFLD: Potential therapeutic targets

(2011) Anne Tailleux et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Human SREBP1c Expression in Liver Is Directly Regulated by Peroxisome Proliferator-activated Receptor α (PPARα)

(2011) Ana Fernández-Alvarez et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Endogenous formation of Nε-(carboxymethyl)lysine is increased in fatty livers and induces inflammatory markers in an in vitro model of hepatic steatosis

(2011) Katrien H.J. Gaens et al.   JOURNAL OF HEPATOLOGY

Human Fatty Liver Disease: Old Questions and New Insights

(2011) J. C. Cohen et al.   SCIENCE

Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c

(2010) P. Ferré et al.   DIABETES OBESITY & METABOLISM

CGX, a traditional Korean medicine ameliorates concanavalin A-induced acute liver injury

(2010) Jang Woo Shin et al.   FOOD AND CHEMICAL TOXICOLOGY

Fatty liver: Role of inflammation and fatty acid nutrition

(2010) Christopher D Byrne   PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS

Resveratrol inhibits the expression of SREBP1 in cell model of steatosis via Sirt1–FOXO1 signaling pathway

(2009) Guang-Li Wang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Fatty liver and lipotoxicity

(2009) Michael Trauner et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Non-alcoholic fatty liver disease pathogenesis: The present and the future

(2009) S. Petta et al.   DIGESTIVE AND LIVER DISEASE

Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-α expression, a novel mechanism for the pathogenesis of NAFLD

(2009) Lin Zheng et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Molecular mechanisms involved in NAFLD progression

(2009) Mariano Malaguarnera et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Nonalcoholic fatty liver disease in children living in the obeseogenic society

(2009) H. Hesham A-Kader   World Journal of Pediatrics

Hepatic steatosis: A benign disease or a silent killer

(2008) Abdel-Rahman El-Zayadi   WORLD JOURNAL OF GASTROENTEROLOGY

PPARα: Mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators

(2007) Frank J. Gonzalez et al.   TOXICOLOGY